Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Liposomes Drugs
1.2.3 Lipid Nanoparticle Drugs
1.3 Market by Application
1.3.1 Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal and Lipid-based Nanoparticle Drug Market Perspective (2018-2029)
2.2 Global Liposomal and Lipid-based Nanoparticle Drug Growth Trends by Region
2.2.1 Liposomal and Lipid-based Nanoparticle Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liposomal and Lipid-based Nanoparticle Drug Historic Market Size by Region (2018-2024)
2.2.3 Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Region (2024-2029)
2.3 Liposomal and Lipid-based Nanoparticle Drug Market Dynamics
2.3.1 Liposomal and Lipid-based Nanoparticle Drug Industry Trends
2.3.2 Liposomal and Lipid-based Nanoparticle Drug Market Drivers
2.3.3 Liposomal and Lipid-based Nanoparticle Drug Market Challenges
2.3.4 Liposomal and Lipid-based Nanoparticle Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Liposomal and Lipid-based Nanoparticle Drug by Players
3.1.1 Global Liposomal and Lipid-based Nanoparticle Drug Revenue by Players (2018-2024)
3.1.2 Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share by Players (2018-2024)
3.2 Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Liposomal and Lipid-based Nanoparticle Drug Market Concentration Ratio
3.4.1 Global Liposomal and Lipid-based Nanoparticle Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal and Lipid-based Nanoparticle Drug Revenue in 2022
3.5 Global Key Players of Liposomal and Lipid-based Nanoparticle Drug Head office and Area Served
3.6 Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Product and Application
3.7 Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal and Lipid-based Nanoparticle Drug Breakdown Data by Type
4.1 Global Liposomal and Lipid-based Nanoparticle Drug Historic Market Size by Type (2018-2024)
4.2 Global Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Type (2024-2029)
5 Liposomal and Lipid-based Nanoparticle Drug Breakdown Data by Application
5.1 Global Liposomal and Lipid-based Nanoparticle Drug Historic Market Size by Application (2018-2024)
5.2 Global Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Liposomal and Lipid-based Nanoparticle Drug Market Size (2018-2029)
6.2 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type
6.2.1 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024)
6.2.2 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029)
6.2.3 North America Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
6.3 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application
6.3.1 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024)
6.3.2 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029)
6.3.3 North America Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
6.4 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country
6.4.1 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024)
6.4.3 North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size (2018-2029)
7.2 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Type
7.2.1 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024)
7.2.2 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029)
7.2.3 Europe Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
7.3 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Application
7.3.1 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024)
7.3.2 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029)
7.3.3 Europe Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
7.4 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country
7.4.1 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024)
7.4.3 Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Liposomal and Lipid-based Nanoparticle Drug Market Size (2018-2029)
8.2 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Type
8.2.1 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024)
8.2.2 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029)
8.2.3 China Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
8.3 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Application
8.3.1 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024)
8.3.2 China Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029)
8.3.3 China Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size (2018-2029)
9.2 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Type
9.2.1 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024)
9.2.2 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029)
9.2.3 Asia Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
9.3 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Application
9.3.1 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024)
9.3.2 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029)
9.3.3 Asia Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
9.4 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region
9.4.1 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region (2018-2024)
9.4.3 Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Liposomal and Lipid-based Nanoparticle Drug Introduction
11.1.4 Johnson & Johnson Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Details
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Liposomal and Lipid-based Nanoparticle Drug Introduction
11.2.4 Sun Pharmaceutical Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.2.5 Sun Pharmaceutical Recent Developments
11.3 CSPC
11.3.1 CSPC Company Details
11.3.2 CSPC Business Overview
11.3.3 CSPC Liposomal and Lipid-based Nanoparticle Drug Introduction
11.3.4 CSPC Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.3.5 CSPC Recent Developments
11.4 Kinyond
11.4.1 Kinyond Company Details
11.4.2 Kinyond Business Overview
11.4.3 Kinyond Liposomal and Lipid-based Nanoparticle Drug Introduction
11.4.4 Kinyond Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.4.5 Kinyond Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Liposomal and Lipid-based Nanoparticle Drug Introduction
11.5.4 Teva Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.5.5 Teva Recent Developments
11.6 Fudan-Zhangjiang
11.6.1 Fudan-Zhangjiang Company Details
11.6.2 Fudan-Zhangjiang Business Overview
11.6.3 Fudan-Zhangjiang Liposomal and Lipid-based Nanoparticle Drug Introduction
11.6.4 Fudan-Zhangjiang Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.6.5 Fudan-Zhangjiang Recent Developments
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila Liposomal and Lipid-based Nanoparticle Drug Introduction
11.7.4 Zydus Cadila Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.7.5 Zydus Cadila Recent Developments
11.8 TTY Biopharma
11.8.1 TTY Biopharma Company Details
11.8.2 TTY Biopharma Business Overview
11.8.3 TTY Biopharma Liposomal and Lipid-based Nanoparticle Drug Introduction
11.8.4 TTY Biopharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.8.5 TTY Biopharma Recent Developments
11.9 Pacira
11.9.1 Pacira Company Details
11.9.2 Pacira Business Overview
11.9.3 Pacira Liposomal and Lipid-based Nanoparticle Drug Introduction
11.9.4 Pacira Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.9.5 Pacira Recent Developments
11.10 Luye Pharma
11.10.1 Luye Pharma Company Details
11.10.2 Luye Pharma Business Overview
11.10.3 Luye Pharma Liposomal and Lipid-based Nanoparticle Drug Introduction
11.10.4 Luye Pharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.10.5 Luye Pharma Recent Developments
11.11 Leadiant Biosciences
11.11.1 Leadiant Biosciences Company Details
11.11.2 Leadiant Biosciences Business Overview
11.11.3 Leadiant Biosciences Liposomal and Lipid-based Nanoparticle Drug Introduction
11.11.4 Leadiant Biosciences Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.11.5 Leadiant Biosciences Recent Developments
11.12 Ipsen
11.12.1 Ipsen Company Details
11.12.2 Ipsen Business Overview
11.12.3 Ipsen Liposomal and Lipid-based Nanoparticle Drug Introduction
11.12.4 Ipsen Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.12.5 Ipsen Recent Developments
11.13 Sayre Therapeutics
11.13.1 Sayre Therapeutics Company Details
11.13.2 Sayre Therapeutics Business Overview
11.13.3 Sayre Therapeutics Liposomal and Lipid-based Nanoparticle Drug Introduction
11.13.4 Sayre Therapeutics Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.13.5 Sayre Therapeutics Recent Developments
11.14 Jazz
11.14.1 Jazz Company Details
11.14.2 Jazz Business Overview
11.14.3 Jazz Liposomal and Lipid-based Nanoparticle Drug Introduction
11.14.4 Jazz Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.14.5 Jazz Recent Developments
11.15 Alnylam
11.15.1 Alnylam Company Details
11.15.2 Alnylam Business Overview
11.15.3 Alnylam Liposomal and Lipid-based Nanoparticle Drug Introduction
11.15.4 Alnylam Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.15.5 Alnylam Recent Developments
11.16 Bausch Health
11.16.1 Bausch Health Company Details
11.16.2 Bausch Health Business Overview
11.16.3 Bausch Health Liposomal and Lipid-based Nanoparticle Drug Introduction
11.16.4 Bausch Health Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.16.5 Bausch Health Recent Developments
11.17 Acrotech Biopharma
11.17.1 Acrotech Biopharma Company Details
11.17.2 Acrotech Biopharma Business Overview
11.17.3 Acrotech Biopharma Liposomal and Lipid-based Nanoparticle Drug Introduction
11.17.4 Acrotech Biopharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.17.5 Acrotech Biopharma Recent Developments
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Liposomal and Lipid-based Nanoparticle Drug Introduction
11.18.4 Takeda Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.18.5 Takeda Recent Developments
11.19 Chiesi Farmaceutici
11.19.1 Chiesi Farmaceutici Company Details
11.19.2 Chiesi Farmaceutici Business Overview
11.19.3 Chiesi Farmaceutici Liposomal and Lipid-based Nanoparticle Drug Introduction
11.19.4 Chiesi Farmaceutici Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.19.5 Chiesi Farmaceutici Recent Developments
11.20 Gilead Sciences
11.20.1 Gilead Sciences Company Details
11.20.2 Gilead Sciences Business Overview
11.20.3 Gilead Sciences Liposomal and Lipid-based Nanoparticle Drug Introduction
11.20.4 Gilead Sciences Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
11.20.5 Gilead Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Liposomes Drugs
Table 3. Key Players of Lipid Nanoparticle Drugs
Table 4. Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Liposomal and Lipid-based Nanoparticle Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Region (2018-2024)
Table 8. Global Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Region (2024-2029)
Table 10. Liposomal and Lipid-based Nanoparticle Drug Market Trends
Table 11. Liposomal and Lipid-based Nanoparticle Drug Market Drivers
Table 12. Liposomal and Lipid-based Nanoparticle Drug Market Challenges
Table 13. Liposomal and Lipid-based Nanoparticle Drug Market Restraints
Table 14. Global Liposomal and Lipid-based Nanoparticle Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Liposomal and Lipid-based Nanoparticle Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Liposomal and Lipid-based Nanoparticle Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal and Lipid-based Nanoparticle Drug as of 2022)
Table 17. Global Liposomal and Lipid-based Nanoparticle Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Liposomal and Lipid-based Nanoparticle Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Headquarters and Area Served
Table 20. Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Product and Application
Table 21. Global Key Players of Liposomal and Lipid-based Nanoparticle Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Liposomal and Lipid-based Nanoparticle Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Liposomal and Lipid-based Nanoparticle Drug Revenue Share by Application (2018-2024)
Table 29. Global Liposomal and Lipid-based Nanoparticle Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Liposomal and Lipid-based Nanoparticle Drug Revenue Share by Application (2024-2029)
Table 31. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Liposomal and Lipid-based Nanoparticle Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Liposomal and Lipid-based Nanoparticle Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Liposomal and Lipid-based Nanoparticle Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Liposomal and Lipid-based Nanoparticle Drug Product
Table 66. Johnson & Johnson Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 67. Johnson & Johnson Recent Developments
Table 68. Sun Pharmaceutical Company Details
Table 69. Sun Pharmaceutical Business Overview
Table 70. Sun Pharmaceutical Liposomal and Lipid-based Nanoparticle Drug Product
Table 71. Sun Pharmaceutical Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 72. Sun Pharmaceutical Recent Developments
Table 73. CSPC Company Details
Table 74. CSPC Business Overview
Table 75. CSPC Liposomal and Lipid-based Nanoparticle Drug Product
Table 76. CSPC Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 77. CSPC Recent Developments
Table 78. Kinyond Company Details
Table 79. Kinyond Business Overview
Table 80. Kinyond Liposomal and Lipid-based Nanoparticle Drug Product
Table 81. Kinyond Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 82. Kinyond Recent Developments
Table 83. Teva Company Details
Table 84. Teva Business Overview
Table 85. Teva Liposomal and Lipid-based Nanoparticle Drug Product
Table 86. Teva Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 87. Teva Recent Developments
Table 88. Fudan-Zhangjiang Company Details
Table 89. Fudan-Zhangjiang Business Overview
Table 90. Fudan-Zhangjiang Liposomal and Lipid-based Nanoparticle Drug Product
Table 91. Fudan-Zhangjiang Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 92. Fudan-Zhangjiang Recent Developments
Table 93. Zydus Cadila Company Details
Table 94. Zydus Cadila Business Overview
Table 95. Zydus Cadila Liposomal and Lipid-based Nanoparticle Drug Product
Table 96. Zydus Cadila Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 97. Zydus Cadila Recent Developments
Table 98. TTY Biopharma Company Details
Table 99. TTY Biopharma Business Overview
Table 100. TTY Biopharma Liposomal and Lipid-based Nanoparticle Drug Product
Table 101. TTY Biopharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 102. TTY Biopharma Recent Developments
Table 103. Pacira Company Details
Table 104. Pacira Business Overview
Table 105. Pacira Liposomal and Lipid-based Nanoparticle Drug Product
Table 106. Pacira Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 107. Pacira Recent Developments
Table 108. Luye Pharma Company Details
Table 109. Luye Pharma Business Overview
Table 110. Luye Pharma Liposomal and Lipid-based Nanoparticle Drug Product
Table 111. Luye Pharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 112. Luye Pharma Recent Developments
Table 113. Leadiant Biosciences Company Details
Table 114. Leadiant Biosciences Business Overview
Table 115. Leadiant Biosciences Liposomal and Lipid-based Nanoparticle Drug Product
Table 116. Leadiant Biosciences Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 117. Leadiant Biosciences Recent Developments
Table 118. Ipsen Company Details
Table 119. Ipsen Business Overview
Table 120. Ipsen Liposomal and Lipid-based Nanoparticle Drug Product
Table 121. Ipsen Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 122. Ipsen Recent Developments
Table 123. Sayre Therapeutics Company Details
Table 124. Sayre Therapeutics Business Overview
Table 125. Sayre Therapeutics Liposomal and Lipid-based Nanoparticle Drug Product
Table 126. Sayre Therapeutics Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 127. Sayre Therapeutics Recent Developments
Table 128. Jazz Company Details
Table 129. Jazz Business Overview
Table 130. Jazz Liposomal and Lipid-based Nanoparticle Drug Product
Table 131. Jazz Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 132. Jazz Recent Developments
Table 133. Alnylam Company Details
Table 134. Alnylam Business Overview
Table 135. Alnylam Liposomal and Lipid-based Nanoparticle Drug Product
Table 136. Alnylam Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 137. Alnylam Recent Developments
Table 138. Bausch Health Company Details
Table 139. Bausch Health Business Overview
Table 140. Bausch Health Liposomal and Lipid-based Nanoparticle Drug Product
Table 141. Bausch Health Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 142. Bausch Health Recent Developments
Table 143. Acrotech Biopharma Company Details
Table 144. Acrotech Biopharma Business Overview
Table 145. Acrotech Biopharma Liposomal and Lipid-based Nanoparticle Drug Product
Table 146. Acrotech Biopharma Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 147. Acrotech Biopharma Recent Developments
Table 148. Takeda Company Details
Table 149. Takeda Business Overview
Table 150. Takeda Liposomal and Lipid-based Nanoparticle Drug Product
Table 151. Takeda Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 152. Takeda Recent Developments
Table 153. Chiesi Farmaceutici Company Details
Table 154. Chiesi Farmaceutici Business Overview
Table 155. Chiesi Farmaceutici Liposomal and Lipid-based Nanoparticle Drug Product
Table 156. Chiesi Farmaceutici Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 157. Chiesi Farmaceutici Recent Developments
Table 158. Gilead Sciences Company Details
Table 159. Gilead Sciences Business Overview
Table 160. Gilead Sciences Liposomal and Lipid-based Nanoparticle Drug Product
Table 161. Gilead Sciences Revenue in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024) & (US$ Million)
Table 162. Gilead Sciences Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Type: 2022 VS 2029
Figure 3. Liposomes Drugs Features
Figure 4. Lipid Nanoparticle Drugs Features
Figure 5. Global Liposomal and Lipid-based Nanoparticle Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Liposomal and Lipid-based Nanoparticle Drug Report Years Considered
Figure 11. Global Liposomal and Lipid-based Nanoparticle Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Liposomal and Lipid-based Nanoparticle Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Liposomal and Lipid-based Nanoparticle Drug Market Share by Players in 2022
Figure 15. Global Top Liposomal and Lipid-based Nanoparticle Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal and Lipid-based Nanoparticle Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Liposomal and Lipid-based Nanoparticle Drug Revenue in 2022
Figure 17. North America Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
Figure 19. North America Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
Figure 20. North America Liposomal and Lipid-based Nanoparticle Drug Market Share by Country (2018-2029)
Figure 21. United States Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Liposomal and Lipid-based Nanoparticle Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
Figure 25. Europe Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
Figure 26. Europe Liposomal and Lipid-based Nanoparticle Drug Market Share by Country (2018-2029)
Figure 27. Germany Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Liposomal and Lipid-based Nanoparticle Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
Figure 35. China Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
Figure 36. Asia Liposomal and Lipid-based Nanoparticle Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
Figure 38. Asia Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
Figure 39. Asia Liposomal and Lipid-based Nanoparticle Drug Market Share by Region (2018-2029)
Figure 40. Japan Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Liposomal and Lipid-based Nanoparticle Drug Market Share by Country (2018-2029)
Figure 50. Brazil Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Liposomal and Lipid-based Nanoparticle Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Johnson & Johnson Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 57. Sun Pharmaceutical Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 58. CSPC Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 59. Kinyond Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 60. Teva Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 61. Fudan-Zhangjiang Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 62. Zydus Cadila Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 63. TTY Biopharma Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 64. Pacira Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 65. Luye Pharma Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 66. Leadiant Biosciences Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 67. Ipsen Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 68. Sayre Therapeutics Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 69. Jazz Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 70. Alnylam Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 71. Bausch Health Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 72. Acrotech Biopharma Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 73. Takeda Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 74. Chiesi Farmaceutici Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 75. Gilead Sciences Revenue Growth Rate in Liposomal and Lipid-based Nanoparticle Drug Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed